Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05252949 · ClinicalTrials.gov registry record · NA
OEA for Targeting Lipid Metabolism in GWI
A NA study, sponsored by Roskamp Institute.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT05252949 is a NA study that has completed, run by Roskamp Institute. The registered enrollment target is 52 participants.
The verdict
NCT05252949, a NA study, has completed, sponsored by Roskamp Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The study is a single site, randomized, double-blind, placebo-controlled study with an open label extension to evaluate the effects of Oleoylethanolamine (OEA) on blood lipid and immune biomarkers in participants with Gulf War Illness (GWI).
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Oleoylethanolamide (OEA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-06-10 |
| Est. Completion | 2025-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05252949
The ClinicalTrials.gov registry entry for NCT05252949 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roskamp Institute, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05252949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05252949 about?
NCT05252949 is a clinical study titled "OEA for Targeting Lipid Metabolism in GWI". The study is a single site, randomized, double-blind, placebo-controlled study with an open label extension to evaluate the effects of Oleoylethanolamine (OEA) on blood lipid and immune biomarkers in participants with Gulf War Illness (GWI).
What is the current status of trial NCT05252949?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2021-06-10. Estimated completion is 2025-01-30.
What interventions are being tested in trial NCT05252949?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Oleoylethanolamide (OEA) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05252949?
This trial is sponsored by Roskamp Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.